Hikma Pharmaceuticals PLC (fra:H5P) Share Price

Company Profile

Business description
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.
Contact
1 New Burlington Place
LondonW1S 2HR
GBR
T: +44 2073992760
E: [email protected]
https://www.hikma.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
9,500

Recommended

Central bankers are likely to hold interest rates steady, but Wall Street is focused on life after Powell.

Sarah Hansen | 26 January 2026

Higher diesel prices and foreign exchange hit unit cash costs.

Jon Mills, CFA | 26 January 2026

Undervalued by 24%, this wide-moat stock is a buy now.

Phelix Lee | 26 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,260.00	1.50	0.02%
CAC 40	8,131.15	11.90	-0.15%
DAX 40	24,933.08	32.37	0.13%
Dow JONES (US)	49,412.40	313.69	0.64%
FTSE 100	10,148.85	5.41	0.05%
HKSE	27,068.97	303.45	1.13%
NASDAQ	23,601.36	100.11	0.43%
Nikkei 225	53,017.71	132.46	0.25%
NZX 50 Index	13,443.49	17.25	-0.13%
S&P 500	6,950.23	34.62	0.50%
S&P/ASX 200	8,935.20	8.50	0.10%
SSE Composite Index	4,131.89	0.72	-0.02%